Lam Research
LRCX
755 hedge funds and large institutions have $28.4B invested in Lam Research in 2017 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 273 increasing their positions, 288 reducing their positions, and 64 closing their positions.
42% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 64
38% more funds holding in top 10
Funds holding in top 10: 26 → 36 (+10)
30% more capital invested
Capital invested by funds: $21.8B → $28.4B (+$6.61B)
2% more funds holding
Funds holding: 739 → 755 (+16)
5% less repeat investments, than reductions
Existing positions increased: 273 | Existing positions reduced: 288
9.06% less ownership
Funds ownership: 955.81% → 946.75% (-9.1%)
39% less call options, than puts
Call options by funds: $312M | Put options by funds: $508M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSLI
Nan Shan Life Insurance
Taipei City,
Taiwan
|
+$145M |
| 2 |
Goldman Sachs
New York
|
+$139M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$120M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$111M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$102M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$315M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$313M |
| 3 |
Morgan Stanley
New York
|
-$100M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$82M |
| 5 |
D.E. Shaw & Co
New York
|
-$80.4M |
LRCX Hedge Fund Activity: Q3 2017 in Review
755 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Lam Research (LRCX) for Q3 2017, worth a combined $28.4B — up 30% from $21.8B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new LRCX positions and 64 closed out — a net gain of 27 holders — while 273 added to existing stakes and 288 trimmed.
The largest buyer was Nan Shan Life Insurance, adding an estimated $145M. The largest seller was Ameriprise, cutting an estimated $315M.
- 755 institutional investors held Lam Research (LRCX) as of Q3 2017, up from 739 in Q2 2017.
- Funds reported $28.4B of Lam Research stock for Q3 2017, up 30% quarter-over-quarter.
- 91 funds opened new Lam Research positions in Q3 2017 and 64 closed out, a net change of +27 holders.
- The largest Lam Research buyer in Q3 2017 was Nan Shan Life Insurance, an estimated $145M added.
- The largest Lam Research seller in Q3 2017 was Ameriprise, an estimated $315M sold.
Based on aggregated 13F filings for Q3 2017.